European Molecular Biology Laboratory Scientists Found Start-Up Company, Elara Pharmaceuticals GmbH To Develop Anti-Cancer Drugs
Published: Aug 09, 2006
Today EMBL scientists, EMBL's commercial affiliate, EMBL Enterprise Management Technology Transfer GmbH [EMBLEM] and EMBL's venture vehicle, EMBL Ventures GmbH, announce the foundation of Elara Pharmaceuticals GmbH, a start-up company that will translate basic research findings into new anti-cancer drugs. Elara is a spinout company dedicated to drug development and will follow-up on promising small molecule leads that have shown powerful anti-cancer actions in screening experiments. Elara receives seed funding from EMBL Ventures and has been granted exclusive license rights to selected discoveries made at EMBL.